First Manhattan CO Invitae Corp Transaction History

First Manhattan CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$1.71 - $3.61 $171 - $361	-100 Reduced 9.09%	1,000 $1,000
Q1 2022 May 16, 2022	SELL	$6.28 - $15.59 $4,427 - $10,990	-705 Reduced 39.06%	1,100 $8,000
Q3 2021 Nov 15, 2021	BUY	$24.31 - $33.6 $2,552 - $3,528	105 Added 6.18%	1,805 $51,000
Q1 2021 May 14, 2021	BUY	$33.06 - $56.93 $56,202 - $96,781	1,700 New	1,700 $64,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

Stay updated on First Manhattan CO with notifications on news.